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Abstract
Mice lacking HIP/RPL29, a component of the ribosomal machinery, display increased bone fragility.
To understand the effect of sub-efficient protein synthetic rates on mineralized tissue quality, we
performed dynamic and static histomorphometry and examined the mineral properties of both bones
and teeth in HIP/RPL29 knock-out mice using Fourier transform infrared imaging (FTIRI). While
loss of HIP/RPL29 consistently reduced total bone size, decreased mineral apposition rates were not
significant, indicating that short stature is not primarily due to impaired osteoblast function.
Interestingly, our microspectroscopic studies showed that a significant decrease in collagen
crosslinking during maturation of HIP/RPL29-null bone precedes an overall enhancement in the
relative extent of mineralization of both trabecular and cortical adult bones. This report provides
strong genetic evidence that ribosomal insufficiency induces subtle organic matrix deficiencies which
elevates calcification. Consistent with the HIP/RPL29-null bone phenotype, HIP/RPL29-deficient
teeth also showed reduced geometric properties accompanied with relative increased mineral
densities of both dentin and enamel. Increased mineralization associated with enhanced tissue
fragility related to imperfection in organic phase microstructure evokes defects seen in matrix
protein-related bone and tooth diseases. Thus, HIP/RPL29 mice constitute a new genetic model for
studying the contribution of global protein synthesis in the establishment of organic and inorganic
phases in mineral tissues.
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Introduction
Ribosomal proteins (RPs) play important regulatory functions in the ribosome and help
maintain a normal protein synthetic rate. In recent years, several mutations in genes encoding
RPs or proteins involved in ribosome biogenesis have been associated with human birth defects
with clinical features that include skeletal growth deficiencies and/or deformities [1]. These
observations strongly link the fundamental processes of ribosome synthesis, growth, and
skeletogenesis. Because of profound effects on embryonic viability, very few RP mutations
have been characterized in mammals [2,3]. Our group generated the first viable null mouse
mutant model lacking an individual ribosomal protein [4]. In these mutants, the loss of the
eukaryote-specific RP of the 60S large ribosomal subunit, HIP/RPL29, resulted in low birth
weight accompanied by a global skeletal growth defect that persisted into adulthood. Reduced
rates of cellular proliferation and global protein synthesis have been proposed to be the cause
of this runting phenotype. Interestingly, the HIP/RPL29-null phenotype in mice is consistent
with data reported in yeast (S. cerevisiae), where the deletion of the RPL29 gene is accompanied
with delayed growth and protein biosynthesis rates [5]. In this unicellular eukaryote, RPL29
was found to contribute to the proper association between the two ribosomal subunits and,
consequently, in mRNA translational efficiency. The absence of an ortholog for RPL29 in
prokaryotes supports the idea that RPL29 plays a role in increasing protein translation rates
under high demand rather than as a core component of the ribosome translational machinery.
Previously, we reported that HIP/RPL29 expression in the growth plate of developing long
bones of mouse embryos is primarily in proliferating and differentiating matrix-producing
chondrocytes and is down-regulated in terminally differentiated hypertrophic chondrocytes
[6]. Recent comparison of HIP/RPL29-deficient and control growth plates indicated that the
reduction in the overall volume occupied by dividing chondrocytes seen in the absence of HIP/
RPL29 is due to the slower progression of chondroprogenitors through the cell cycle [7]. These
early changes in the kinetics of osteogenesis are believed to be responsible for the observed
bone shortening. Sub-efficient protein synthesis in HIP/RPL29-null bone precursor cells is
believed to be responsible for decrease rates of ECM protein production which, in turn, may
result in increased fragility in adult HIP/RPL29-deficient long bones [7]. Immunodetection
studies demonstrated that HIP/RPL29 is present at the surface of perinuclear membranes of
the rough endoplasmic reticulum and also is associated with translationally active ribosomes
after polysomal fractionation [4]. HIP/RPL29’s predominant subcellular localization at sites
where translation of secreted proteins takes place suggests an important role for HIP/RPL29
in modulating the synthesis of secreted proteins including those of the extracellular matrix
(ECM).
Bone is a two-phase composite material and its quality is determined by the relative amounts
and structure of organic and mineral (hydroxyapatite) phases [8]. During skeletal growth, the
rapid but regulated production of ECM protein is crucial for the establishment of normal bone
mass and microarchitecture. Dietary or genetic protein deficiencies during skeletal
development or in early life can impair bone microstructure and reduce its mechanical
properties [7,9,10]. Notably, mutations in the genes that encode for the main component of
bone ECM, type I collagen, result in a severe increase in fracture risk [11]. In addition, genetic
disruption of type I collagen also was found to impact dental health by inducing structural
defects in collagen fibrils of dentin [12]. Other mutations in genes encoding for non-
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collagenous proteins such as DMP-1 are also known to affect the relative distribution of organic
versus inorganic phases leading to abnormal mineralization in both bone and teeth.
In the present study, we examined the consequences of HIP/RPL29 absence on bone formation
potential and analyzed variation in mineral properties of mutant and wild type bones and teeth
using Fourier transform infrared microspectrocopic imaging (FTIRI). We hypothesized, based
on previous evidence of sub-efficient rates of protein synthesis, that the contribution of the
organic phase is reduced in mutant bone and teeth (resulting in a relative increase in mineral-
to-matrix ratio) and that subtle organic matrix imperfections are responsible for the previously
reported fragility phenotype [7].
Materials and methods
Experimental Animals and Statistics
Hip/Rpl29tm2Udel null and control mice (1, 3, and 6 month-old) in a C57BL6/J background
were obtained as described [4]. Because distinct skeletal phenotype differences were not
observed between wild type (WT) and heterozygous animals, both genotypes were used as
controls for histomorphometric studies [7]. Only WT and null animals were characterized by
FTIRI. Statistical comparisons between control and null animals were performed using a two-
tailed Student’s t-test. All animal handling experiments complied with the University of
Delaware IACUC approved guidelines.
Static and Dynamic Histomorphometry
After extraction, WT and HIP/RPL29 null mice bones (n≥4) were fixed immediately for 4-5
days in 4% (w/v) phosphate buffered formalin and stored in 70% (v/v) ethanol until further
processing. For dynamic histomorphometry, bones were double-labeled with calcein at 3
months of age (first label=day 0, second label=day 8), and euthanized on day 11 post-injection.
Histology of the distal metaphysis of femora was performed by the Histomorphometry and
Molecular Analysis Core Laboratory of the Center for Metabolic Bone Disease (University of
Alabama at Birmingham). Longitudinal sections (5 μm-thick) were cut from MMA plastic
embedded blocks along the frontal plane and stained with Goldner’s Trichrome stain for static
measurements of trabecular indices. Additional 10 μm-thick sections were obtained and left
unstained for dynamic measurements. Histomorphometry was performed using the Bioquant
Image Analysis System (R&M Biometrics, Nashville, TN, USA) as described [13] and as
recommended by the Nomenclature Committee of the American Society of Bone and Mineral
Research [14]. Single-labeled and double-labeled fluorescent surface measurements were
obtained in a cancellous region of bone that measured approximately 2.5 mm2 which was
located 0.5–2.5 mm proximally to the epiphyseal growth cartilage of the femurs and contained
only secondary spongiosa.
Bone FTIRI Analysis
Sections (2-3 μm-thick) of all WT and Hip/Rpl29tm2Udel null bone samples were mounted on
BaF2 spectral windows and examined using a FTIRI (Perkin Elmer Spotlight 300 Imaging
Spectrometer, Perkin Elmer Instruments, Shelton, CT, USA) with a spectral resolution of 8
cm−1 and a spatial resolution of approximately 7 μm. Cortical and cancellous bone areas were
examined separately, and 3-5 areas of each type were examined per bone. Because no
significant difference was observed between genders for most of the bone parameters
examined, male and female FTIRI data were combined into either a WT or a RPL29-null
category (n≥8 for each group). Background spectra were collected under identical conditions
from the same BaF2 windows. After acquisition, spectra were truncated to allow analysis of
the spectral data of interest, baseline was corrected, and the spectral contribution of the
polymethyl methacrylate (PMMA)-embedding media was subtracted using ISYS software
Sloofman et al. Page 3













[15]. Spectra were processed to yield images corresponding to infrared band areas, peak height
ratios and integrated area ratios by a combination of instrument software and ISYS chemical
imaging software (version 3.1, Spectral Dimensions Inc., Olney, MD, USA). In spectral
images, all pixels lacking any matrix and/or mineral absorbance were considered devoid of
tissue, and set equal to zero and subsequently excluded from all calculations.
The following spectroscopic parameters were determined: mineral-to-matrix ratio [v1, v3 PO4
band (900-1180 cm−1) / amide I band (1596-1712 cm−1)], collagen crosslink ratio of intensities
(1660 cm−1/1690 cm−1), carbonate-to-mineral ratio [carbonate band (852-900 cm−1)/ v1, v3
PO4 band 900-1180 cm−1], and crystallinity (ratio of intensities 1030 cm−1/1020 cm−1), a value
corresponding to the crystallite size and perfection determined by X-ray diffraction line
broadening analysis. All spectroscopic results were expressed as histograms, detailing the pixel
distribution of the parameters, mean values and standard deviations of the pixel distribution.
Corresponding color-coded hyperspectral images (where x, and y are the locations on the
specimen and z the intensity of the peak or calculated ratio at each pixel) were generated
concurrently by ISYS for all parameters.
Tooth Micro-Computed Tomography and FTIRI Analysis
Right hemimandibles of 3 month-old Hip/Rpl29tm2Udel null and age-matched WT mice (n≥11
for each group) were excised and fixed in 10% formalin. The hemimandibles were placed in
70% ethanol and the molar-bearing segment was selected for analysis by micro-computed
tomography (micro-CT) on a Scanco μCT35 scanner (Scanco Medical, Basserdorf,
Switzerland) with a 6 μm voxel size. A 0.36 degrees rotation step (360 degrees angular range),
400 ms exposure and 4 frames per view were used in the scans. The Scanco micro-CT software
(HP, DECwindows Motif 1.6) was used for 3D reconstruction and viewing of images.
Anatomical crown volumes of interest were defined with a free-hand tool on sequential slices
of the reconstructed molar volumes to include enamel and dentin areas. Root volumes of
interest were produced by digital subtraction of the crown volume from the whole molar volume
(Fig. 1A). The distribution of mineral densities within the crown and root ROIs was exported
as a text file and processed on Excel (Microsoft Corporation, Redmond WA, USA) for crown
and root volumes, dentin and enamel volumes, and mean mineral densities of enamel, crown
dentin and root dentin. A global pulp-dentin and dentin-enamel mineral density threshold was
defined on the distribution of mineral densities within crown volumes of interest for these
measurements (Fig. 1B). Because no significant gender difference was observed, male and
female micro-CT data were pooled (n≥11) for each genotype examined.
The left hemimandibles of WT and null female animals were partially fixed in 70% ethanol
and were used for the FTIRI analysis of the molar dentin (n≥4). The molar-bearing part of the
hemimandibles was cut away from the rest of the jaw, dehydrated, embedded in PMMA and
2 μm-thick sections obtained on BaF2 windows as already described for the bone analyses.
Approximately 1 mm × .5 mm fields around the first and second molar crowns were scanned
with a 7 μm spatial and 4 cm−1 spectral resolution. Bone and background areas in the scanned
fields were masked. The molar crown dentin images were processed for mineral and matrix
properties as described above, after a co-addition of all spectra in the masked image process
as described before [16]. This co-addition was performed to minimize the effect of thin enamel
fragments remaining in the dentin section (enamel essentially is fractured away during
sectioning).
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Morphological properties of HIP/RPL29−/− mice
Histological analysis of distal metaphyses of 6 month-old HIP/RPL29-null femora showed no
obvious morphological abnormalities in their general architecture when compared to control
littermates (Fig. 2A-D) other than the overall significant 25% decrease in total tissue area
recently reported [7]. Thus, only a proportionate size decrease and pronounced reduction in
bone marrow area are seen in HIP/RPL29-null versus control mice. These observations are
consistent with previous comparative micro-CT analyses of HIP/RPL29-deficient bone
parameters [7]. Although overall thinning of the growth plate (arrows in Fig. 2 E&F) and short
stature are obvious phenotypic traits of adult null mice, von Kossa staining of HIP/RPL29-
deficient bone sections did not reveal striking differences in the relative amount of mineral
deposit when compared to controls at the macroscopic level (Fig. 2A-D).
To further characterize trabecular bone properties in HIP/RPL29-deficient mice, both static
and dynamic histomorphometry analyses were conducted. Because trabeculae are harder to
detect in aging adult mice compared with young maturing bone, histomorphometry of
cancellous bone was performed in young adult 3 month-old femora (Table 1). Interestingly,
even though reduction of global bone geometry is well established in HIP/RPL29-deficient
mice, the reduction in the amount of HIP/RPL29-deficient mineralized bone in a given area
(BV/TV, −15.6% in null vs. controls; p>0.05) was not statistically significant. This data was
associated with non-significant reduction in trabeculae thickness (Tb. thickness, −13.9% in
nulls vs. controls; p=0.529) relative to controls. Additionally, no difference in the number of
osteoblasts/osteoclasts present at the bone surface was noted in the secondary spongiosa
between control and HIP/RPL29-null mice (data not shown). Dynamic calcein labeling
revealed a significant decrease in the mineralizing surface present in HIP/RPL29−/− bones
(−37.5%; p<0.05) when compared to controls. However, this decrease did not reach statistical
significance after normalization to the bone perimeter present in the corresponding region of
interest (MS/BS). Decreases in both the mineral apposition (MAR, −11.6% in nulls vs. controls;
p=0.368) and bone formation (BFR/BS, −19.2% in nulls vs. controls; p=0.387) rates did not
reach statistical significance. Although only subtle impairments were found in the adult bone
turnover of null mice, ex vivo investigation performed in bone precursor cells revealed an
important decrease in the relative amount of ribosomes present in HIP/RPL29-deficient cells
when compared to controls (Supplemental Fig. 1). More importantly, the relative amount of
ribosomal RNAs engaged in translational activity, as indicated by their heavier profiles after
polysomal fractionation, was significantly decreased in HIP/RPL29 null relative to WT
progenitors (Supplemental Fig. 1). Thus, ribosomal insufficiency in HIP/RPL29-null
developing bone tissues is believed to induce changes in morphological features and bone
formation capacity that, in turn, lead to decreased bone quality in adult mice. To elucidate the
factors contributing to the previously described increased brittleness in aging HIP/RPL29−/−
bones [7], we analyzed the mineral properties of mutant trabecular and cortical bone using
vibrational IR microspectroscopy at various ages.
FTIRI of HIP/RPL29−/− and WT bones
Analysis of the mineral-to-matrix ratio of HIP/RPL29-deficient trabecular bone showed a
significant increase in mineral/matrix ratio in 6 month-old mature adult bone when compared
to age-matched WT controls [Fig. 3A, +20.2% in null (n=8) vs. WT (n=9); p=0.02].
Additionally, a significant 23% increase in mineral-to-matrix ratio was seen in null trabecular
bones from 1 to 6 months (p=0.02). In contrast, this parameter only significantly increased in
WT cortical bone as animals aged [Fig. 3D, +12.5% in 6 months (n=13) vs. 1 month (n=10);
p<0.01]. In cortices of 6 month-old, the difference between mineral-to-matrix ratios of HIP/
RPL29-deficient (n = 10) and control bones (n = 13) was smaller, failing to reach statistical
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significance (Fig. 3D, +2.4% in nulls vs. WT; p=0.489). Interestingly, the mineral-to-matrix
ratio of HIP/RPL29-deficient cortical bone was significantly reduced at earlier post-weaning
ages when compared to WT controls [Fig. 3D, −11% in nulls (n=10) vs. WT (n=10); p=0.025].
In cortical bone of HIP/RPL29-null animals, the mineral-to-matrix ratio showed a highly
significant 30% increase from 1 to 6 months (p<0.001), whereas WT animals only showed a
12.5% increase over the same time period (p<0.01). No genotype dependent differences were
found in the mineral-to-matrix ratios at 3 months of age (n≥10). To assess whether the relative
increase in the mineral phase of adult null bones was also detected at a macroscopic level, we
compared the collagen content of null and WT adult femurs using a biochemical approach. No
significant change was found in the quantity of collagen (per dry weight of bone) present in
HIP/RPL29-deficient bone when compared to the amount present in WT bone (Supplementary
Table 1A). Additionally, no genotype-linked difference was noticed in the relative amount of
collagen (% per total protein) and specific amino acid residues (Supplementary Table 1).
Similar results were obtained in tibia (data not shown). Interestingly, although the proline/
hydroxyproline ratio was found normal, the lysine to hydroxylysine ratio noticeably increased
in HIP/RPL29-deficient bones when compared to WT controls (lys/hyl=2.9 in WT and lys/
hyl=4.4 in null mutants) indicating a shift from hydroxylysine to non-modified lysine residues
in the mutant bones (Supplementary Table 1).
In contrast, the XLR parameter indicative of collagen maturity was significantly reduced in
HIP/RPL29-deficient bone at 3 months (n=11) in both cortical and trabecular bone areas, when
compared with WT (n=10) by approximately 10% and 11%, respectively (Fig. 4; p<0.05). This
decrease in the XLR parameter at 3 month of age was slightly more pronounced in null female
trabecular bone than in equivalent null male bone and was diminished by nearly 15% when
compared with age-matched WT female littermates (p<0.05, data not shown). Interestingly,
such a decrease in the XLR parameter was also more apparent in 3 month-old female growth
plates (data not shown). By 6 months, the XLR decrease seen in maturing 3 month-old null
bones was overcome (Fig. 3A, D) and the overall increase in the XLR parameter for null bones
was statistically significant (+17%, 1 month vs. 6 months) and more pronounced than for
control bones.
The carbonate-to-mineral ratio which increases with age and is related to mineral solubility
was slightly elevated in cortices and trabeculae of young HIP/RPL29 null animals but remained
equivalent to the carbonate-to-mineral ratio of WT controls at older ages (n≥10, data not
shown). No significant changes were noted in the size and perfection of hydroxyapatite crystals
in any mutant bone tissue examined as indicated by relatively small changes in the crystallinity
parameter over time and when compared with WT controls (n≥10, data not shown). With the
exception of the XLR parameter in HIP/RPL29−/− trabecular bone where the decrease in
females was more prominent than in males, no significant gender-dependent differences were
noted in null bones when compared to WT controls for all the four parameters examined.
Micro-CT of wild type and HIP/RPL29−/− teeth
Comparative analysis of the structural properties of 3 month-old HIP/RPL29-null (n=12) and
WT (n=10) first molars by micro-CT showed significant decrease of root volume (−11.3%,
p≤0.001, Table 2). A similar observation was made in the second molar where the volume of
HIP/RPL29-null roots also was significantly decreased compared to age-matched WT controls
(Table 2B, −5.3% in nulls vs. WT; p<0.05). Although the dentin and enamel volumes were not
changed between genotypes, small but significant increases in mineral density were found in
HIP/RPL29-deficient first molars relative to their WT counterparts (Table 2A, +2.1% for dentin
and +1.6% for enamel; p≤0.001). A significant increase in dentin mineral content also was
found in second molars (Table 2B, +1.8% in nulls vs. WT; p<0.01). Although no measurement
could be obtained for cementum, a collagenous-based component of tooth roots,
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hypercementosis was found in two of the HIP/RPL29-deficient second molar examined (one
male and one female, n=12) but was never observed in any of the wild type control second
molar (Fig. 5).
In first molars, no significant gender-dependent differences were noted in HIP/RPL29-
deficient when compared with WT controls for any of the parameters examined. Although
trends were conserved in WT and HIP/RPL29-null second molars of both genders, differences
relative to gender-matched WT were more pronounced in null females than in null males (data
not shown). For this reason, further analysis of tooth molecular composition by Fourier
transform microspectroscopy was performed only on female teeth.
FTIRI of wild type and HIP/RPL29−/− teeth
In agreement with the micro-CT results for dentin mineral density, the average mineral-to-
matrix ratio in dentin increased in first and second molars by 6% and 4%, respectively (n=5)
when compared to corresponding WT molars (n=5); however these differences were not
statistically significant (Table 3).
On the other hand, crystallinity was significantly reduced in HIP/RPL29−/− first molars (−8%
in null vs. WT; p<0.05) but not changed in HIP/RPL29−/− second molars. There was no
significant difference among genotypes for the other FTIRI parameters in either first or second
molars.
Discussion
Bones and teeth are mineralized tissues composed of an organic matrix secreted by specialized
cells; hydroxyapatite crystals are embedded in that matrix in an organized fashion. Coordinated
synthesis and secretion of type I collagen and non-collagenous proteins are essential for
establishment of normal tissue mass and mineral distribution in bone, dentin, and root
cementum [17-20]. Thus, it is not surprising that disruption of specific components of the
protein synthetic machinery during development has dramatic consequences on growth and
quality of the adult bone tissue [2,7,21]. In this study, we show that sub-optimal protein
biosynthesis rates [4] in HIP/RPL29-null mice resulted in a proportionate short stature
phenotype that is not associated with a significant decrease in bone apposition rates and
collagen quantity. Additionally, although residual growth plates of HIP/RPL29-deficient adult
bones appeared thinner than in WT controls, columnar chondrocytes and the chondro-osteo
junction remained normally arranged. Thus, the reported 25% reduction in bone volume of
HIP/RPL29-deficient mice is not a direct consequence of changes in osteoblast function and
bone remodeling but may rather be due to reduced ECM protein production and delayed
osteoprogenitor differentiation during bone development [7]. This observation is consistent
with reduced in vitro differentiation potential and decreased translational efficiency in HIP/
RPL29-null osteoblast precursors, and with short stature phenotypes found in Diamond-
Blackfan patients carrying other RP gene mutations known to affect differentiation of bone
marrow precursors [7,22,23].
Our recent work indicated that elevated mineral density in HIP/RPL29-deficient cortices likely
is responsible for increased fragility of long bone shafts [7]. This discovery is in agreement
with the idea that variation in bone growth patterns can be linked with alterations in
biomechanical properties [24]. Here we analyzed further the causes of diminished bone quality
in HIP/RPL29-deficient mice by defining the relative distribution of organic versus inorganic
phases and reporting important changes in the matrix composition of both cortical and
trabecular bone using FTIRI. This study shows that homozygous deletion of the Hip/Rpl29
gene in mice is accompanied by an increase in the relative mineral content of adult bone
compared to their age matched WT counterparts. This increase in mineral-to-matrix ratio is
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reminiscent of local microhardness and increased mineral content noted in a murine model
(oim) of osteogenesis imperfecta (OI) in which the gene encoding for the major matrix
component, alpha2 type I collagen gene, is disrupted resulting a higher mineral-to-matrix ratio
[11,25,26]. However, unlike in oim/oim mice in which specific disorganization of collagen
matrix is observed, HIP/RPL29 null mutation does not induce changes in terms of global
collagen content and composition in bone. Thus, the observed imbalance in the ratio of the two
bone phases and poor mechanical properties of HIP/RPL29-deficient bones are more likely
attributable to more subtle changes in organic matrix arrangement. Typically, stabilization of
bone tissue by elevation of its mineral content comes at the cost of increased brittleness and
raises fracture risk. Likewise, sub-efficient protein biosynthesis in HIP/RPL29-null developing
bone tissues results in abnormal mineral-to-matrix ratio and increased mineral content that may
contribute to increased fragility [7].
Although the contribution of the mineral phase is believed to be the primary modulator of
bone’s toughness, this study shows strong genetic evidence that the organic phase is also an
important determinant of bone’s unique material properties and is in agreement with studies
performed by others [25,27]. Here, we demonstrate that the bone matrix of a mouse model of
ribosomal insufficiency displays collagen crosslinking imperfections during the maturation
phase followed by a hypermineralization phenotype at an age when peak bone mass is reached.
Similar observations were made in the primary spongiosa of developing growth plate cartilage
that serves as a template for endochondral bone formation. Since bone collagen crosslinks
utilize hydroxyproline for stability, a decrease in the relative level of hydroxylysine versus
lysine supports the idea that HIP/RPL29 mutant bone quality is affected. Because collagen
forms the template upon which the mineral is deposited and collagen fibrils within the HIP/
RPL29 knockout are presumably less compacted (lower XLR/less mature), local increase in
sites available for mineral deposition could occur [18]. However, additional molecular
evaluations will be needed to determine whether disarrangement of the collagen network during
bone maturation is responsible for subsequent matrix-to-mineral ratio decrease in fully mature
bone. Future studies will consist of determining if imperfections in the microstructure of the
organic phase are related to abnormal mineralization foci using electron microscopy during
critical stages of bone maturation. Interestingly, although the XLR parameter was diminished
in both male and female mice, females’ trabecular bone displayed even lower XLR values
indicating that sex partially modulated the effect of the genotype for this parameter. This data
is in accordance with previous observations that HIP/RPL29 null males can partially
compensate for decreased geometric properties but not null females [7].
Thus, global ribosomal insufficiency during bone growth appears to be at the origin of abnormal
mineral deposition at older age suggesting an indirect role for HIP/RPL29 in the regulation of
matrix mineralization. In contrast, specific non-collagenous proteins, such as osteopontin and
DMP-1 were found to have a more active role to play in biomineralization as either inhibitor
or initiator/regulator of mineral formation and crystal growth, respectively [28-30]. This
observation agrees with our finding that the crystallinity parameter is unchanged in HIP/
RPL29-deficient bone when compared to age-matched controls at all stages examined.
To determine the effect of HIP/RPL29 depletion on another mineralized tissue, we compared
the structural and compositional properties of young adult teeth and noticed that the phenotype
in the HIP/RPL29-null tooth is quite similar to that of the bone. First, the decrease in micro-
CT measurements for HIP/RPL29−/− first and second molars versus age-matched WT teeth is
in good agreement with the global skeletal growth deficiencies reported previously [4].
Interestingly, this geometrical decrease was more pronounced in the root areas, and might be
due to the fact that root morphogenesis takes place after crown formation postnatally and cannot
be as easily rescued through maternal circulation and lactation. Second, the club shape
hypercementosis phenotype found in two out of the twelve HIP/RPL29-null first molar roots
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examined is indicative of an increase in cementum deposition and the presence of abnormal
mineralization foci [31]; which is consistent with the hypermineralization phenotype found in
HIP/RPL29-deficient bones. This idea is reinforced by a significant increase in the mineral
density of dentin, and, to a lesser extent of enamel, in the first molars of HIP/RPL29-null mice
when compared to age-matched controls. In the second molar, which is developmentally
delayed relative to the first molar, only dentin mineral density was significantly increased in
mutant teeth versus WT. Like for bone, this data indicates an elevated risk of tooth
microfracture and fragility associated with aging in mice with altered protein synthesis rates.
Similarly, increased hardness and dentin fragility occurs in mice which exhibit mutations in
either the major structural protein present in dentin (type I collagen) or non collagenous protein
such as DMP-1 [28,32]. The lower genotype effect observed in HIP/RPL29-deficient enamel
might be inherent to the nature of enamel which contains little protein, none of which is collagen
[33].
The detailed mineral analysis of the teeth based on infrared microspectroscopy showed that
the mineral-to-matrix ratio was noticeably increased in HIP/RPL29 deficient teeth whereas the
crystallinity, which is an indicator of crystal size and purity was significantly decreased in HIP/
RPL29-null first molars relative to age-matched WT controls. Smaller crystal size in mutant
teeth is suggestive of a developmental delay when compared with controls. Although an
increase in mineral density with decreased crystal size has not been reported previously in teeth
it has been described in cases of osteopetrotic bone diseases [34]. Additional studies will be
necessary to determine whether the reduction in crystallinity in HIP/RPL29 null mutant teeth
is corrected during aging and results primarily from delayed morphogenesis.
In summary, we determined that deficiency in a component of the protein synthesis machinery
induces defects in the relative distribution and/or structural organization of the mineral and
organic phases of bone tissue, dentin and possibly cementum that subsequently lead to the
relative hypermineralization of both bones and teeth, respectively. Elevated material properties
and increase in fragility of mineralized tissues evokes defects reminiscent of matrix protein-
related genetic bone and tooth diseases making this model useful for studying the effects of
protein deficiencies on mineralization.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Micro-CT of molars
A: Definition of the crown volume of interest on sequential slices-3D rendering of the crown
volume (right) B: Distribution of mineral densities within a crown volume.
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Figure 2. Histological comparison of mature bone in HIP/RPL29-deficient and control mice
Consecutive non-decalcified von Kossa (A, B) and Goldner’s trichrome (C, D) -stained
sections of the epiphyseal bone, growth plate, and metaphyseal bone of 6-month old HIP/
RPL29−/− (B, D; n=6) and controls (A, C; n=4) mice. The decrease of mineral deposits in the
absence of HIP/RPL29 reflected a decrease in the global geometric properties of null mutant
bone relative to controls. Note the rapid narrowing of the bone marrow cavity (horizontal
arrows) in null mutants (B, D). Closer examination of HIP/RPL29−/− tibial growth plates (E,
F) after decalcification and hematoxylin/eosin staining indicated well organized columnar
arrangement of chondrocytes and reduced overall thickness compared to controls (vertical
arrows in E and F).
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Figure 3. FTIR microspectroscopic analysis of the bone mineral-to-matrix ratio of HIP/RPL29-
null and age-matched WT mice
Mean values obtained from at least eight animals for the area of phosphate band and the area
of amide I band at sites below the growth plate and at mid-shaft for trabecular and cortical
bone, respectively (A, D). Whereas the mineral-to-matrix ratio (v1,v3 PO4 area /amide I area)
is first below average in HIP/RPL29-deficient younger bone when compared with WT it
becomes increased in older bone, with statistical significance in 6 month-old trabecular bones
(+20.2% in nulls, n = 8 vs. WT, n = 9; *p<0.05). Typical spectral infrared images of 6 month-
old trabecular (B, C) and cortical bone (E, F) are shown. For mean value comparison in the
same genotype in 6 months (n≥8) versus 1 month (n≥10), the p values are as follows: # p<0.05,
## p<0.01, ### p<0.001.
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Figure 4. FTIR microspectroscopic analysis of the collagen crosslinking parameter in HIP/RPL29-
null and age-matched WT bones
The mean values obtained from at least eight animals in cortical (A) and trabecular bone (B)
for collagen crosslinking (intensity ratio 1660/1690) are significantly reduced in HIP/RPL29-
deficient bone (n=11) at 3 months (*p<0.05) compared with WT (n=10) but restored to control
levels in older bones. Significant increase in collagen crosslinking is seen in older null animals
compared to nulls at post-weaning age (# p<0.05 and ### p<0.001 in 6 months vs. 1 month,
n=10). Typical spectral infrared images of 3 month-old trabecular (C, D) are shown. Highest
values normally present in the center of the trabeculae in WT are absent in HIP/RPL29-deficient
bones.
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Figure 5. Hypercementosis in HIP/RPL29-null second molars
Tridimensional micro-CT reconstruction of HIP/RPL29−/− (A, n=12) and WT (B, n=10)
second molars at three months. The arrow indicates a club shape hypercementosis phenotype
in a HIP/RPL29-deficient molar.
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Table 1
Static and Dynamic Histomorphometry
Controls Hip/Rpl29−/−
BV/TV 10.28 (+/− 6.88) 8.67 (+/− 3.86)
Bone Perimeter (BS) mm 6.01 (+/− 4.53) 6.03 (+/− 1.45)
BS/BV (mm-1) 62.96 (+/− 10.48) 69.33 (+/− 14.96)
BS/TV (mm-1) 5.57 (+/− 2.45) 5.62 (+/− 1.69)
Trabecular Thickness (μm) 34.87 (+/− 12.49) 30.01 (+/− 7.04)
Trabecular Number (mm-1) 2.78 (+/− 1.23) 2.81 (+/− 0.85)
Trabecular Space (μm) 385.69 (+/− 191.54) 360.70 (+/− 158.94)
Mineralizing surface/MS (mm) 3.65 (+/− 1.13) 2.28 (+/− 1.22) *
MS/BS 35.56 (+/− 9.33) 33.03 (+/− 13.10)
Mineral Apposition Rate (MAR) μm/day 1.54 (+/− 0.29) 1.36 (+/− 0.43)
Bone Form Rate (BFR/BS) μm/day 0.55 (+/− 0.22) 0.45 (+/−0.21)
*
p< 0.05; Controls consist of both WT and HIP/RPL29+/− mice. Hip/Rpl29−/− and controls (n≥4). Data are mean +/− SD.
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Table 2
Comparative tooth micro-computed tomography analysis
Controls (WT) HIP/RPL29−/− % change vs.control
A. First Molar
Total volume (mm3) 1.18 (+/− 0.05) 1.09 (+/− 0.07) −7.6% **
Crown volume (mm3) 0.47 (+/− 0.02) 0.47 (+/− 0.04) No change
Root volume (mm3) 0.71 (+/− 0.04) 0.63 (+/− 0.06) −11.3% ***
Dentin volume (mm3) 0.32 (+/− 0.01) 0.31 (+/− 0.03) No change
Enamel volume (mm3) 0.12 (+/− 0.01) 0.12 (+/− 0.01) No change
Dentin mineral density (mg/cc) 1268 (+/− 15) 1295 (+/− 17) 2.1% ***
Enamel mineral density (mg/cc) 1910 (+/− 26) 1940 (+/− 27) 1.6% **
B. Second Molar
Total volume (mm3) 0.66 (+/− 0.04) 0.64 (+/− 0.03) −3%
Crown volume (mm3) 0.28 (+/− 0.01) 0.28 (+/− 0.02) No change
Root volume (mm3) 0.38 (+/− 0.03) 0.36 (+/− 0.02) −5.3% *
Dentin volume (mm3) 0.17 (+/− 0.01) 0.17 (+/− 0.01) No change
Enamel volume (mm3) 0.08 (+/− 0.01) 0.09 (+/− 0.01) 12.5%
Dentin mineral density (mg/cc) 1290 (+/− 24) 1313 (+/− 14) 1.8% **
Enamel mineral density (mg/cc) 1934 (+/− 43) 1955 (+/− 24) 1.1%
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Table 3
Tooth Fourier transform-infrared imaging (FTIRI) analysis
Controls (WT) Hip/Rpl29−/− % null change vs.control
A. First Molar
Crystallinity 1.2 (+/− 0.02) 1.1 (+/− 0.03) −8% *
Mineral/matrix 9.4 (+/− 0.97) 10 (+/− 1.12) 6%
Crosslinking 2.9 (+/− 0.23) 3 (+/− 0.25) 3%
B. Second Molar
Crystallinity 1.1 (+/− 0.02) 1.1 (+/− 0.04) No change
Mineral/matrix 9.8 (+/− 0.65) 10.2 (+/− 1.22) 4%
Crosslinking 3.3 (+/− 0.49) 3.2 (+/− 0.26) −3%
Hip/Rpl29−/− (n=5) and WT (n=5). Data are mean +/− SD.
*
p<0.05
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